Overview
David Combarel practices practicing medicine in Villejuif, France.
His clinical expertise encompasses Polyhydramnios, Renal Cell Carcinoma (RCC), and PIK3CA-Related Overgrowth Spectrum.
He is actively involved in clinical research, co-authoring 25 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about David Combarel
Is David Combarel a top-rated expert for Polyhydramnios?
MediFind is an objective health platform that identifies experts based on real-world data. David Combarel is classified as an Experienced expert for Polyhydramnios, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does David Combarel participate in research or clinical trials?
Yes. David Combarel has published 25 articles and abstracts on conditions like Polyhydramnios. You can view a list of David Combarel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- PIK3CA-Related Overgrowth SpectrumMr. Combarel isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- PolyhydramniosMr. Combarel isExperienced. Learn about Polyhydramnios.
- Renal Cell Carcinoma (RCC)Mr. Combarel isExperienced. Learn about Renal Cell Carcinoma (RCC).